Study Stopped
CT imaging equipment was upgraded during trial enrollment. Old imaging protocols were no longer compatible with new generation CT. As these were not comparable to previous imaging, study was suspended for analysis and reporting of imaging so far.
The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30
OPTICAP>30
1 other identifier
interventional
30
1 country
1
Brief Summary
This study focuses on the use of contrast enhanced low-dose CT imaging as a modality to differentiate between uncomplicated and complicated acute appendicitis. Accurate differential diagnosis allows the assessment of all available treatment options. Complicated acute appendicitis requires emergency appendectomy, while uncomplicated acute appendicitis can be safely and efficiently treated with antibiotics in the majority of patients. Our study group already published the results of the initial OPTICAP trial enrolling patients with BMI under 30 showing similar accuracy between the low-dose and the stadard dose CT, but a significant dose reduction associated with the low-dose CT. All patients will undergo both imaging protocols as the standard CT is also optimized for a low as possible radiation dosage and imaging sequence per patient is randomized due to the optimization of contrast media injection timing. All patients participating in this study will be treated operatively with a laparoscopic appendectomy to obtain histological confirmation for the diagnosis to evaluate the accuracy of the CT imaging. The aim of this study is to optimize a well-performing low-dose CT imaging protocol to use in the diagnosis of uncomplicated acute appendicitis in patients with body mass index over 30 kg/m2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2020
CompletedFirst Posted
Study publicly available on registry
August 19, 2020
CompletedStudy Start
First participant enrolled
November 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2023
CompletedFebruary 25, 2022
February 1, 2022
1 year
August 17, 2020
February 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The accuracy of low-dose vs. standard CT in diagnosing acute uncomplicated appendicitis in patients with BMI >30
CT accuracy between low-dose and standard CT will be evaluated based on the operative and histopathological findings after laparoscopic appendectomy
30 days
Secondary Outcomes (4)
Negative appendectomy rate
30 days
Appendiceal perforation rate
30 days
Sensitivity and specificity of the imaging protocols
30 days
Radiation dose
30 days
Study Arms (1)
Low-dose CT for acute appendicitis in patients with BMI >30
EXPERIMENTALLow-dose computed tomography (CT) vs. standard CT for diagnosing acute uncomplicated appendicitis in patients with BMI \> 30 Laparoscopic appendectomy
Interventions
Low-dose computed tomography for suspected acute uncomplicated appendicitis in patients with BMI \>30
All patients with BMI \>30, who are diagnosed with an uncomplicated acute appendicitis on low-dose CT-scan will undergo laparoscopic appendectomy to evaluate the sensitivity and specificity of the CT diagnosis
Eligibility Criteria
You may qualify if:
- Age 18-60 years
- Clinical suspicion of acute uncomplicated appendicitis based on history, physical examination, laboratory findings evaluated by a senior surgeon
- Body mass index over 30 kg/m2
You may not qualify if:
- Age \<18 years or \> 60 years
- Pregnancy or breastfeeding
- Allergy to contrast material or iodine
- History of appendectomy
- Renal failure, creatinine-value greater than the upper reference value
- Diabetes mellitus and metformin medication
- Suspicion of peritonitis and appendiceal perforation
- Incapability to cooperate and give consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Turku University hospital
Turku, Southwest Finland, 20521, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paulina Salminen, MD, PhD
Turku University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
August 17, 2020
First Posted
August 19, 2020
Study Start
November 4, 2020
Primary Completion
November 17, 2021
Study Completion
November 17, 2023
Last Updated
February 25, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share
Available from the study PI upon request.